Pgiam/iStock via Getty Images Shares of agilon health ( NYSE: AGL ) traded lower on Wednesday after Citi downgraded the value-based care provider to Sell from Neutral, citing headwinds in the Medicare Advantage market ahead of its Q3 2024 results next week. Additionally, Citi lowered its price target.